Carcinoma, Intraductal, Noninfiltrating

"Carcinoma, Intraductal, Noninfiltrating" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.

Descriptor ID	D002285
MeSH Number(s)	C04.557.470.200.025.275 C04.557.470.200.240.187.250 C04.557.470.615.275
Concept/Terms	Carcinoma, Intraductal, Noninfiltrating Carcinoma, Intraductal, Noninfiltrating Carcinoma, Intraductal Carcinomas, Intraductal Intraductal Carcinoma Intraductal Carcinomas DCIS Ductal Carcinoma In Situ Intraductal Carcinoma, Noninfiltrating Carcinoma, Noninfiltrating Intraductal Carcinomas, Noninfiltrating Intraductal Intraductal Carcinomas, Noninfiltrating Noninfiltrating Intraductal Carcinoma Noninfiltrating Intraductal Carcinomas Atypical Ductal Hyperplasia Atypical Ductal Hyperplasia Atypical Ductal Hyperplasias Ductal Hyperplasia, Atypical Ductal Hyperplasias, Atypical Hyperplasia, Atypical Ductal Hyperplasias, Atypical Ductal

Below are MeSH descriptors whose meaning is more general than "Carcinoma, Intraductal, Noninfiltrating".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Neoplasms, Glandular and Epithelial [C04.557.470]
Carcinoma [C04.557.470.200]
Adenocarcinoma [C04.557.470.200.025]
Carcinoma, Intraductal, Noninfiltrating [C04.557.470.200.025.275]
Carcinoma in Situ [C04.557.470.200.240]
Breast Carcinoma In Situ [C04.557.470.200.240.187]
Carcinoma, Intraductal, Noninfiltrating [C04.557.470.200.240.187.250]
Neoplasms, Ductal, Lobular, and Medullary [C04.557.470.615]
Carcinoma, Intraductal, Noninfiltrating [C04.557.470.615.275]

Below are MeSH descriptors whose meaning is related to "Carcinoma, Intraductal, Noninfiltrating".

Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Intraductal, Noninfiltrating".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Carcinoma, Intraductal, Noninfiltrating" by people in this website by year, and whether "Carcinoma, Intraductal, Noninfiltrating" was a major or minor topic of these publications.

Bar chart showing 21 publications over 18 distinct years, with a maximum of 2 publications in 2015 and 2017 and 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	0	1
2003	1	0	1
2005	1	0	1
2006	1	0	1
2007	0	1	1
2011	1	0	1
2012	1	0	1
2013	1	0	1
2014	1	0	1
2015	2	0	2
2016	1	0	1
2017	2	0	2
2018	1	0	1
2019	1	1	2
2020	1	0	1
2021	1	0	1
2022	1	0	1
2023	1	0	1

Below are the most recent publications written about "Carcinoma, Intraductal, Noninfiltrating" by people in Profiles.

Vicks E, Mason H, Perez Coulter A, Niakan S, Friedrich A, Cho R, Casaubon J. Increased risk of upstage when combinations of breast lesions of uncertain malignant potential are found on core needle biopsy: The need for surgical excision. Am J Surg. 2024 01; 227:6-12.

View in: PubMed
Casaubon J, Niakan S, Vicks E, Perez Coulter A, Jacobbe DL, Mason H. The effect of delay of excisional biopsy on upstage rate for atypical ductal hyperplasia, flat epithelial atypia, intraductal papilloma, and radial scar. Breast Cancer Res Treat. 2022 Dec; 196(3):527-534.

View in: PubMed
McCormick B, Winter KA, Woodward W, Kuerer HM, Sneige N, Rakovitch E, Smith BL, Germain I, Hartford AC, O'Rourke MA, Walker EM, Strom EA, Hopkins JO, Pierce LJ, Pu AT, Sumida KNM, Vesprini D, Moughan J, White JR. Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804. J Clin Oncol. 2021 11 10; 39(32):3574-3582.

View in: PubMed
Zong Y, Montironi R, Massari F, Jiang Z, Lopez-Beltran A, Wheeler TM, Scarpelli M, Santoni M, Cimadamore A, Cheng L. Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives. Eur Urol Focus. 2021 09; 7(5):955-963.

View in: PubMed
Dettogni RS, Stur E, Laus AC, da Costa Vieira RA, Marques MMC, Santana IVV, Pulido JZ, Ribeiro LF, de Jesus Parmanhani N, Agostini LP, Dos Reis RS, de Vargas Wolfgramm Dos Santos E, Alves LNR, Garcia FM, Santos JA, do Prado Ventorim D, Reis RM, Louro ID. Potential biomarkers of ductal carcinoma in situ progression. BMC Cancer. 2020 Feb 12; 20(1):119.

View in: PubMed
Dialani V, Tseng I, Slanetz PJ, Fein-Zachary V, Phillips J, Karimova E, Brook A, Mehta TS. Potential role of abbreviated MRI for breast cancer screening in an academic medical center. Breast J. 2019 07; 25(4):604-611.

View in: PubMed
LaFemina J. Invited Commentary. J Am Coll Surg. 2019 06; 228(6):939-940.

View in: PubMed
Sprague BL, Vacek PM, Herschorn SD, James TA, Geller BM, Trentham-Dietz A, Stein JL, Weaver DL. Time-varying risks of second events following a DCIS diagnosis in the population-based Vermont DCIS cohort. Breast Cancer Res Treat. 2019 Feb; 174(1):227-235.

View in: PubMed
Amornsiripanitch N, Lam DL, Rahbar H. Advances in Breast MRI in the Setting of Ductal Carcinoma In Situ. Semin Roentgenol. 2018 Oct; 53(4):261-269.

View in: PubMed
Bremer T, Whitworth PW, Patel R, Savala J, Barry T, Lyle S, Leesman G, Linke SP, Jirstr?m K, Zhou W, Amini RM, W?rnberg F. A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk. Clin Cancer Res. 2018 12 01; 24(23):5895-5901.

View in: PubMed

People

Explore

Similar Concepts

Top Journals